Cellebrite, the Israeli digital forensics company, reported third-quarter 2026 results today, and the numbers beat the guidance it gave in August. Annual recurring revenue (ARR) reached $528.5 million, up 20% from a year earlier, and quarterly revenue was $149 million, up 18%.
What do the numbers show?
Net income reached $26.7 million and adjusted EBITDA $53.6 million, a 36% margin. Both key figures beat the ranges the company gave in August: $524 million to $528 million for ARR and $145 million to $148 million for revenue. The company expects a free cash flow margin of about 30% for the full year.
What about guidance?
Here the picture is more complex. Cellebrite reaffirmed its year-end ARR guidance of $550 million to $560 million and raised adjusted EBITDA guidance to $163 million to $166 million, from $153 million to $159 million. But it slightly narrowed revenue guidance to $553 million to $558 million, from $555 million to $561 million. The explanation: more revenue comes from cloud subscriptions and AI products, recognized gradually, and less from hardware sales, recognized immediately.
Why does it matter?
This is exactly the shift Cellebrite has been trying to make for several years: from a company selling devices to extract data from phones to a software company selling subscriptions. The shift hurts revenue in the short term but builds steadier, more predictable revenue, which investors reward. And in a week when monday.com was punished for weak guidance, Cellebrite arrives with improving profitability and ARR that beats expectations.
